The Enterprise Value as of November 2024 (TTM) for INmune Bio, Inc. (INMB) is 77.34M

According to INmune Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 77.34M. This represents a change of -46.79% compared to the average of 145.35M of the last 4 quarters.

INmune Bio, Inc. (INMB) Historical Enterprise Value (quarterly & annually)

How has INMB Enterprise Value performed in the past?

The mean historical Enterprise Value of INmune Bio, Inc. over the last ten years is 105.94M. The current 77.34M Enterprise Value has changed 7.20% with respect to the historical average. Over the past ten years (40 quarters), INMB's Enterprise Value was at its highest in in the September 2021 quarter at 266.60M. The Enterprise Value was at its lowest in in the September 2016 quarter at 0.

INmune Bio, Inc. (INMB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of INmune Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

INmune Bio, Inc. (INMB) Average Enterprise Value

How has INMB Enterprise Value performed in the past?

The current Enterprise Value of INmune Bio, Inc. (INMB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

INmune Bio, Inc. (INMB) Enterprise Value vs. Peers

How is INMB’s Enterprise Value compared to its peers?

INmune Bio, Inc.’s Enterprise Value is greater than TFF Pharmaceuticals, Inc. (-1374952.00), greater than Anebulo Pharmaceuticals, Inc. (36.46M), less than Abcam plc (4.54B), greater than AN2 Therapeutics, Inc. (6.48M), greater than Cue Biopharma, Inc. (41.71M), less than Anixa Biosciences, Inc. (101.99M), greater than IN8bio, Inc. (24.49M), greater than PolyPid Ltd. (29.33M), greater than Aerovate Therapeutics, Inc. (46.23M), less than Eliem Therapeutics, Inc. (119.64M), less than Decibel Therapeutics, Inc. (102.82M), less than Anavex Life Sciences Corp. (633.73M), less than Cassava Sciences, Inc. (1.12B), greater than BioVie Inc. (34.57M), greater than Cognition Therapeutics, Inc. (-3660923.00), less than TScan Therapeutics, Inc. (184.60M), greater than Dermata Therapeutics, Inc. (-3823196.00),

Build a custom stock screener for INmune Bio, Inc. (INMB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INmune Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

INmune Bio, Inc. (INMB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like INmune Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.